Increased prevalence of breast cancers will create demand for HER2 antibodies. Moreover, increasing incidence of breast cancer is expected to increase in demand for targeted therapies and boost the growth of HER2 antibodies in the market during the forecast period. HER2 antibodies market segmented on the basis of type of treatment and geography.
Transtuzumab Segment is Expected to Dominate the Market
Based on type of treatment, the HER2 antibodies market is segmented as Transtuzumab, Lapatinib, Adotranstuzumab Emtansine, Pertuzumab, and Everolimus. It has been found that Transtuzumab played an important role in treating breast cancers associated with HER2 proteins. In 2016 Transtuzumab dominated the HER2 antibodies market followed by Everolimus, whereas Pertuzumab is projected for more promising future
Read more Insights at [URL]https://www.precisionbusinessinsights.com/market-reports/her2-antibodies-market/[/URL]
North-America, Accounts for Major Revenue Share for HER2 Antibodies Market
Precision Business Insights (PBI), HER2 antibodies market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, North-America accounted for major revenue share due to increased occurrence of breast cancers in these regions.
Strategic Collaborations Play Vital Role in HER2 Antibodies Market
Collaborations between the market players for the development of HER2 antibodies enhance the revenue of market over the forecast years. For instance, in November 2018, Zymeworks and BeiGene collaborated for development and commercialization of Zymeworks’ investigational ZW25 and ZW49 HER2-targeted bispecific antibodies. HER2 antibodies market players are Genentech Inc. (F. Hoffmann-La Roche Ltd.), Novartis AG, Pfizer, Inc., Abnova Corporation, InvivoGen, Celltrion, Inc., Biocon Limited, Zymeworks, Inc., BeiGene, Ltd. and Bio-Techne (Novus Biologicals, LLC) and some other players who are involved in the HER2 antibodies market.
Avail free sample report at [URL]https://precisionbusinessinsights.com/request-sample?product_id=22956[/URL]
Detailed Segmentation
By Type
o Trastuzumab
o Lapatinib
o Ado-trastuzumab emtansine
o Pertuzumab
o Everolimus
o Others
Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
Geography
o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact us
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @www.precisionbusinessinsights.com